باب
Mirdametinib
رقم CAS
391210-10-9
الصيغة الجزيئية
C16H14F3IN2O4
وزن جزيئي
482.2
نقاء

Not less than-95.0%

مرادف

(R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide; Benzamide, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide; N-[((R)-2,3-Dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide; N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

الكلمات الرئيسية
Pharmaceutical Standards
Impurities
Intermediates
Mirdametinib Standard

Mirdametinib is used in patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. It works by selectively inhibiting MEK1 and MEK2 enzymes in the MAPK pathway, which is overactive in NF1. This helps to reduce abnormal cell growth, shrink tumors, relieve pain, improve mobility or function, and delay disease progression